Financial News
Press Releases about Horizon Therapeutics
![](https://mms.businesswire.com/media/20221116005151/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221116005403/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221110005428/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221108005040/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221105005026/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221031005857/en/1619992/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221101005467/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Horizon Therapeutics plc Named to the Seramount Inclusion Index
November 01, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221027005604/en/1616328/5/Q32BIO_-_green_logo_-_white_bg_-_RGB.jpg)
![](https://mms.businesswire.com/media/20221026005180/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221022005001/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221013005131/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221012005275/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221006005632/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221006005160/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20221002005046/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220929005249/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220922005025/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220921005110/en/1577697/5/Solve-logo.jpg)
![](https://mms.businesswire.com/media/20220919005319/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220916005051/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220914005234/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220913005239/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220912005374/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220908005904/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Horizon Therapeutics plc Announces $500 Million Share Repurchase Program
September 09, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220908005292/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220831005502/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20220828005031/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220825005272/en/1460023/5/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg)
![](https://mms.businesswire.com/media/20220815005203/en/1543694/5/Q32BIO_-_green_logo_-_white_bg_-_RGB.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.